Contact
Please use this form to send email to PR contact of this press release:
First Patient Treated in Mapi Pharma’s Phase II Clinical Trial of GA Depot for Primary Progressive Multiple Sclerosis (PPMS)
TO:
Please use this form to send email to PR contact of this press release:
First Patient Treated in Mapi Pharma’s Phase II Clinical Trial of GA Depot for Primary Progressive Multiple Sclerosis (PPMS)
TO: